https://www.bloomberg.com/news/articles/2022-04-01/china-weighs-giving-u-s-full-access-to-audits-of-most-firms?srnd=markets-vp
Recent BGNE News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/08/2025 11:02:32 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/07/2025 09:18:38 PM
- TEVIMBRA erhält US-Marktzulassung für die Erstlinienbehandlung von Magen- und GEJ-Tumoren in Kombination mit Chemotherapie • Business Wire • 12/28/2024 04:50:00 PM
- Le TEVIMBRA est approuvé aux États-Unis pour le traitement de première intention des cancers gastrique et de la jonction gastro-œsophagienne en association avec une chimiothérapie • Business Wire • 12/27/2024 08:06:00 PM
- TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy • Business Wire • 12/27/2024 11:00:00 AM
- BeiGene ändert am 2. Januar Nasdaq Tickersymbol in “ONC"; auf der 43. Annual J.P. Morgan Healthcare Conference präsent • Business Wire • 12/23/2024 07:42:00 PM
- ベイジーン、1月2日にナスダックのティッカーシンボルを「ONC」に変更、第43回J.P. モルガン・ヘルスケア・カンファレンスでプレゼンテーションを予定 • Business Wire • 12/23/2024 04:53:00 PM
- BeiGene adoptera le mnémo « ONC » au Nasdaq à partir du 2 janvier et répondra présent à la 43e édition de la conférence annuelle de J.P. Morgan Healthcare • Business Wire • 12/23/2024 03:47:00 PM
- BeiGene將於1月2日將那斯達克股票代號更改為「ONC」,並將出席第43屆J.P. Morgan醫療健康年會 • Business Wire • 12/23/2024 03:47:00 PM
- BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference • Business Wire • 12/23/2024 11:00:00 AM
- BeiGene gibt globale Lizenzvereinbarung für MAT2A-Inhibitor bekannt • Business Wire • 12/13/2024 09:43:00 AM
- BeiGene annonce un accord de licence mondial pour l’inhibiteur MAT2A • Business Wire • 12/13/2024 09:21:00 AM
- BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor • Business Wire • 12/13/2024 12:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2024 10:18:09 PM
- ベイジーンがASH 2024で新データを発表、BRUKINSA®や新規パイプライン資産などの血液学分野でCLLにおけるリーダーシップを向上 • Business Wire • 12/12/2024 01:10:00 PM
- BeiGene在ASH 2024上憑藉來自其血液學特許產品(包括BRUKINSA®)的新資料和新型研發產品線資產提升在CLL領域的領導地位 • Business Wire • 12/11/2024 02:49:00 AM
- BeiGene stärkt Führungsposition bei CLL mit neuen Daten aus dem Hämatologie-Franchise – darunter BRUKINSA® und neue Pipeline-Assets • Business Wire • 12/11/2024 02:45:00 AM
- BeiGene renforce son leadership dans la LLC à l’ASH 2024 avec de nouvelles données issues de sa franchise hématologique comprenant BRUKINSA® et de nouveaux actifs en cours de développement • Business Wire • 12/11/2024 02:36:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2024 01:19:56 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/10/2024 09:26:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2024 11:02:43 AM
- BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets • Business Wire • 12/10/2024 01:30:00 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 12/04/2024 09:05:33 PM
- BeiGene and CLL Society Partner to Advance Test Before Treat™ Campaign, Promoting Biomarker Testing to Improve Patient Outcomes in CLL • Business Wire • 12/04/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/03/2024 02:45:14 AM
FEATURED Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 • Mar 10, 2025 9:05 AM
North Bay Resources Announces Assays up to 5.69% Copper, 1 Opt. Silver, and 0.22% Vanadium at Copper Island Project, British Columbia • NBRI • Mar 10, 2025 9:00 AM
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare • AVAI • Mar 10, 2025 8:00 AM
Veri Medtech (VRHI) Network Grows To 400 Physicians • VRHI • Mar 10, 2025 7:32 AM
One World Products' Isiah Thomas Issues Investor Update • OWPC • Mar 6, 2025 9:19 AM
Authentic Holdings To Reduce Debt by over $2 Million While Achieving Substantial Revenue Growth • AHRO • Mar 6, 2025 8:00 AM